| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |